Lazard

Lazard is out with its report today on Marvell Technology (NASDAQ: MRVL), reiterating Buy. In its report, Lazard writes, "We recommend MRVL as a stock to own for the following reasons: 1) Upside from wireless exists as the company is positioning itself well in the opportunity around TD-SCDMA which...

Lazard is out with its report today on Micron Technology (NYSE: MU), maintaining Buy. In its report, Lazard writes, "Results last night reflect our thesis that the stock is largely range bound in the near term, with significant upside potential once we see demand return to the DRAM mkt. While...

Lazard is out with its report today on Cavium (NASDAQ: CAVM), lowering its PT from $40 to $37. In its report, Lazard writes, "CAVM lowered its 3Q revenue guidance yesterday from an increase of 2%-3% sequentially Q/Q ($73.4M at midpt) to a decrease of 4%-6% Q/Q ($68M at midpt) due to weakness in...

Lazard is out with its report today on Broadcom (NASDAQ: BRCM), maintaining Buy. In its report, Lazard writes, "Our PT of $48 is 17x FY2011E PF EPS, a multiple that reflects BRCM's historical average. We believe that the current multiple remains attractive considering the risk-reward in owning a...

Shares of OmniVision Technologies (NASDAQ: OVTI) are plunging more than 30% today after the company guided sharply lower than expected, and many are wondering whether the company is being squeezed out of the iPhone, or perhaps Apple (NASDAQ: AAPL) is squeezing the margins of yet another supplier....

Lazard believes the fair value of Alkermes (NASDAQ: ALKS) is $25/share.

African nation Ivory Coast said it is unable to make debt payments for the rest of the year, and is seeking “a complete reassessment” of $2.3 billion of Eurobonds. The move stems from the massive fighting the country has seen since the election. Civil war broke out in the country former...

According to Citi, Lazard (NYSE: LAZ) Hold rating is reiterated. Citi said that, given slowing announced M&A volumes, macro weakness, and lower global equity markets, we trim our LAZ ests for 2011 by $0.25 to $2.25 (vs cons of $2.47), 2012 by $0.35 to $2.75 (vs cons of $3.07) and 2013 by $0.45...

Citigroup has lowered the price target on Lazard (NYSE: LAZ) from $47 to $42 and maintains its Hold rating.

KBW is out with its report today on Lazard (NYSE: LAZ), reiterating Outperform. In a note to clients, KBW writes, "LAZ shares are down 8.4% MTD and trade at just 15.6x our 2011E & less than 12x 2012E; we strongly reiterate our Outperform rating and $52 SOTP price target. There have been 14...